The pharmaceutical industry has encountered hitherto unheard-of problems in recent years. In the previous three years, the average cost of pharmaceuticals has increased by 24% in the US due to safety concerns, problems with specific prescriptions, and competition from both non-generic and generic drugs. Prescription costs for those with private insurance decreased by 4% as a result between 2010 and 2013.Similar issues are seen in growing markets such as China, India, and Brazil. One potential solution is to develop a range of medically beneficial vaccinations.Antibiotics are necessary to treat bacterial infections and keep populations and individuals healthy over the long run. However, antibiotic-resistant bacterial infections are a global health concern.